Delafloxacin: A bigger and better fluoroquinolone?
| Overview / Abstract: |
This application-based continuing pharmacy education activity will provide a "journal club format" discussion for pharmacists and student pharmacists ondelafloxacin, a fluoroquinolone recently approved by the FDA approved for skinand soft tissue infections. Join us to discuss the key trial leading to its approval as well as highlight clinical pearls to clarify its place in therapy for patients in your practice. |
|
Expiration |
Jun 03, 2021 |
|
Discipline(s) |
Pharmacy CPE |
|
Format |
Online, Webinar / Webcast / Video |
|
Cost |
$9.00 |
|
Credits / Hours |
0.15 |
|
Accreditation |
ACPE |
|
Presenters / Authors / Faculty |
Christina Rivera, PharmD, BCPS |
|
Keywords / Search Terms |
CEI ce, law, federal, pharmacy, update, legislative, regulatory, pbm, provider status, act |
|